Barclays analyst Luke Sergott raised the price target on West Pharmaceutical (NYSE: WST) to $310.00 (from $275.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE